Obesity and the risk of gallbladder cancer: a meta-analysis by Larsson, S C & Wolk, A
Obesity and the risk of gallbladder cancer: a meta-analysis
SC Larsson*,1 and A Wolk
1
1Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE-17177 Stockholm, Sweden
We performed a meta-analysis of studies of the association between excess body weight and risk of gallbladder cancer identified
from MEDLINE and EMBASE databases from 1966 to February 2007 and the references of retrieved articles. A random-effects
model was used to combine results from eight cohort studies and three case–control studies, with a total of 3288 cases. Compared
with individuals of ‘normal weight’, the summary relative risk of gallbladder cancer for those who were overweight or obese was 1.15
(95% CI, 1.01–1.30) and 1.66 (95% CI, 1.47–1.88) respectively. The association with obesity was stronger for women (relative risk,
1.88; 95% CI, 1.66–2.13) than for men (relative risk, 1.35; 95% CI, 1.09–1.68). There was no statistically significant heterogeneity
among the results of individual studies. This meta-analysis confirms the association between excess body weight and risk of
gallbladder cancer.
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Cancer of the gallbladder is a highly fatal malignancy, usually
diagnosed at an advanced stage, with a 5-year survival rate of less
than 10% (Misra et al, 2003). Although rare in most parts of
Europe and in the United States, relatively high incidence and
mortality rates are found in northern India, Chile, Pakistan, Korea
and some eastern European countries (Randi et al, 2006).
Gallbladder cancer is about two to five times more common in
women than in men. Little is known about the aetiology of this
neoplasm besides a strong link with gallstones (Randi et al, 2006).
Obesity increases the risk for gallstones, and thus may be a risk
factor of gallbladder cancer. Because the epidemiologic evidence
on excess body weight and risk of gallbladder cancer has not yet
been quantitatively summarised, we conducted a meta-analysis of
cohort and case–control studies on this subject.
METHODS
Study selection
We conducted a computerised search of the MEDLINE and
EMBASE databases for studies that were published from 1966 to
February 2007, using the Medical Subject Headings or text words
‘body mass index’, ‘BMI’, ‘obesity’, or ‘weight’ combined with
‘gallbladder cancer’ or ‘gallbladder neoplasm’. In addition, we
manually searched the reference lists of retrieved articles for
additional relevant studies. No language restrictions were imposed.
Studies were included in the meta-analysis if they met the
following criteria: (1) cohort or case–control study in which
gallbladder cancer incidence or mortality was an outcome; (2) the
exposure of interest was overweight and/or obesity defined by
body mass index (BMI) (the weight in kilograms divided by the
square of height in metres) and (3) estimates of relative risk (rate
ratio, odds ratio, or standardised incidence ratio) with their
corresponding 95% confidence intervals were reported. When
there were multiple publications from the same study population,
we included the one with the largest sample size.
We identified eight cohort studies (Møller et al, 1994; Wolk et al,
2001; Calle et al, 2003; Samanic et al, 2004, 2006; Engeland et al,
2005; Kuriyama et al, 2005; Oh et al, 2005) and four case–control
studies (Zatonski et al, 1992, 1997; Strom et al, 1995; Serra et al,
2002) that reported results on overweight/obesity and risk of
gallbladder cancer. One case–control study (Zatonski et al, 1992)
was excluded because this study was included in a multicentre
case–control study (Zatonski et al, 1997); the multicentre case–
control study was included in this meta-analysis.
Data extraction
For each study, the following data were extracted: first author’s last
name; publication year; country in which the study was performed;
study design; source of controls (in case–control studies); sample
size; method of assessment of weight and height (self-reported or
measured); type of outcome (incidence or mortality); covariates
for adjustments in the analysis and the risk estimates with
corresponding 95% confidence intervals. From each study, we
extracted the risk estimates that reflected the greatest degree of
adjustment for potential confounders.
Statistical analysis
Relative risk was used as the measure of the association between
BMI and gallbladder cancer. Because gallbladder cancer is a rare
disease, odds ratios and standardised incidence ratio provide a
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risk for simplicity. The relative risks and corresponding standard
errors (derived from the confidence intervals) from individual
studies were logarithmically transformed to stabilise variances and
normalise the distributions. We computed summary relative risk
estimates for two categories of BMI as defined by the World Health
Organisation (WHO) for adults: overweight (BMI 25–30kgm
 2)
and obesity (BMI X30kgm
 2) compared with ‘normal’ weight
(BMI 18.5–24.9kgm
 2) as the reference category. Where non-
standard categories of BMI were used, we chose the category that
was most similar to those defined by the WHO. Study-specific
estimates were combined using the DerSimonian and Laird
random-effects model, which incorporates both within- and
between-study variation (DerSimonian and Laird, 1986).
Statistical heterogeneity among studies was evaluated with the Q
and I
2 statistics (Higgins and Thompson, 2002). For the Q statistic,
statistical significance was set at Po0.1. A meta-regression
analysis was performed to investigate whether the association
between obesity and risk of gallbladder cancer differed by study
design or sex. We conducted a sensitivity analysis, in which one
study at a time was removed and the rest analysed to assess
whether the results were markedly affected by a single study. We
used funnel plots (i.e., plots of study results against precision) to
assess publication bias, and tested its symmetry (Egger et al, 1997).
Results are presented graphically, whereby squares represent
study-specific estimates and diamonds represent summary esti-
mates. The area of each square is proportional to the inverse of the
variance of the logarithm of the relative risk; 95% confidence
intervals for individual studies are represented by horizontal lines
and for the summary estimates by the width of the diamonds.
All statistical analyses were performed with Stata, version 9.0
(StataCorp, College Station, TX, USA).
Population-attributable risk (PAR) for gallbladder cancer was
estimated for individuals with excess body weight (BMI X25kgm
 2)
compared with those of normal weight (BMI o25kgm
 2). The
PAR describes the theoretical proportion of cases that would be
prevented if all individuals were moved into the exposure level
associated with the lowest risk for that factor. The PAR (PAR%)
was calculated as PAR%¼(p (RR 1)/(p (RR 1)þ1)) 100%,
where p represents the prevalence in the population and RR the
relative risk. Prevalence data were obtained from the National
Health and Nutrition Examination Survey that assessed the
prevalence of overweight and obesity in a representative sample
of the US population (Ogden et al, 2006). In that survey, 39.7% of
the men were overweight and 31.1% were obese. Among women,
28.6% were overweight and 33.2% were obese. PARs were
calculated for the overweight and obese categories using the
obtained summary relative risk estimates, and then summarised
across the two categories for men and women separately.
RESULTS
The eight cohort studies (Møller et al, 1994; Wolk et al, 2001; Calle
et al, 2003; Samanic et al, 2004, 2006; Engeland et al, 2005;
Kuriyama et al, 2005; Oh et al, 2005) and three case–control
studies (Strom et al, 1995; Zatonski et al, 1997; Serra et al, 2002)
that were included in the meta-analysis involved a total of 3288
cases. Main characteristics of the studies are shown in Table 1.
Weight and height were measured in three studies (Engeland et al,
2005; Oh et al, 2005; Samanic et al, 2006) and self-reported in five
studies (Strom et al, 1995; Zatonski et al, 1997; Serra et al, 2002;
Calle et al, 2003; Kuriyama et al, 2005); in three studies, obesity
was defined by a discharge diagnosis of obesity (Møller et al, 1994;
Wolk et al, 2001; Samanic et al, 2004). Among case–control
studies, one used population-based controls (Zatonski et al, 1997)
and two used hospital-based controls (Strom et al, 1995; Serra
et al, 2002).
Relative risk estimates of gallbladder cancer for ‘obesity’
compared with ‘normal weight’ in individual studies (separately
for men and women wherever this information was available) and
all studies combined are shown in Figure 1. Of the 18 relative risk
estimates from the 11 studies, 14 were above one, of which eight
were statistically significant. Meta-analysis of all studies found that
compared to individuals with ‘normal weight’, those who were
‘obese’ had a 66% increased risk with no statistically significant
heterogeneity among individual studies (Figure 1). In a sensitivity
analysis, no single study appreciably influenced the summary
relative risk, which ranged from 1.59 to 1.73 when omitting
individual studies one at a time. The relation with obesity did not
differ – statistically – significantly by study design (P¼0.56)
(Figure 1). However, the summary estimate was higher (P¼0.02)
for women (RR, 1.88; 1.66–2.13) than for men (RR, 1.35; 95% CI,
1.09–1.68). Summary relative risks were 1.82 (95% CI, 1.37–2.42)
for studies based on self-report, 1.60 (95% CI, 1.29–1.98) for those
with weight and height measurements and 1.51 (95% CI, 1.20–
1.91) for those based on a discharge diagnosis of obesity. There
was some indication of publication bias on the funnel plot (data
not shown), suggesting the relative absence of small studies with
null results; the Egger’s test yielded a P-value of 0.05.
Eight studies presented relative risk estimates for ‘overweight’
compared with ‘normal weight’ (Strom et al, 1995; Zatonski et al,
1997; Serra et al, 2002; Calle et al, 2003; Engeland et al, 2005;
Kuriyama et al, 2005; Oh et al, 2005; Samanic et al, 2006). Meta-
analysis of these studies found those in the overweight category
had a statistically significant 15% increased risk (RR, 1.15; 95% CI,
1.01–1.30) compared to those of normal weight, with no
statistically significant heterogeneity among studies (Q¼14.93;
P¼0.19; I
2¼26.3). The summary relative risk did not differ –
statistically – significantly by study design (P¼0.86), but was
higher (P¼0.09) for women (RR, 1.28; 95% CI, 1.04–1.57) than
men (RR, 1.05; 95% CI, 0.92–1.19). We found no evidence of
publication bias on the funnel plot (data not shown) or by Egger’s
test (P¼0.87).
The PAR for excess body weight was calculated using the
estimates of prevalence in the United States (Ogden et al, 2006)
and the obtained summary relative risks for overweight (1.05 for
men and 1.28 for women) and obesity (1.35 for men and 1.88 for
women). We estimated that 12% of the gallbladder cancer cases
among men and 30% among women could be attributable to
excess body weight (BMI X25kgm
 2).
DISCUSSION
This meta-analysis of published studies indicates that the risk of
gallbladder cancer increases with increasing BMI. Summary results
showed that gallbladder cancer risk was 15 and 66% higher among
those who were overweight and obese, respectively, as compared
with those of normal weight. The association between obesity and
gallbladder cancer risk was stronger in women than in men.
Several potential limitations should be considered when
interpreting the results from this meta-analysis. First, because of
the observational design of the included studies, we cannot rule
out the possibility that the observed association between excess
body weight and risk is owing to confounding from other risk
factors. Second, five studies (Strom et al, 1995; Zatonski et al, 1997;
Serra et al, 2002; Calle et al, 2003; Kuriyama et al, 2005) in this
meta-analysis relied on self-reported weight and height and it is
possible that weight has been under-reported, particularly by
overweight or obese individuals (IARC, 2002). The summary
relative risk estimate was higher for studies that relied on self-
reported weight and height. In case–control studies, weight loss
before the cancer diagnosis would attenuate the relative risk
estimates. The summary relative risk estimate was slightly lower
for case–control studies than for cohort studies. Findings from
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control group were more health conscious and thus less likely to
be overweight or obese than the cases. Finally, there was some
suggestion of publication bias. The presence of publication bias
could have led to an overestimation of the true association between
obesity and risk of gallbladder cancer.
Potential biological mechanisms for the association include
increased concentrations of endogenous hormones (estrogens,
insulin, and insulin-like growth factor-I) in overweight and obese
individuals. Obesity may increase risk indirectly by increasing the
risk of gallstones, which, in turn, increase the risk for gallbladder
cancer (Randi et al, 2006). The reason for the stronger association
observed with obesity in women than in men is unclear. The three
studies that found that obesity was associated with an increased
risk in men only were all based on a small number of male cases in
the obese category (Møller et al, 1994; Zatonski et al, 1997; Wolk
et al, 2001), so the stronger association observed in women may be
due to chance.
Table 1 Characteristics of the 11 studies included in the meta-analysis
Relative risk
a (95% CI)
Study (country)
Study
design
Cases
(men/women)
Controls or
cohort size
(men/women)
BMI (kgm
–2)
categories Men Women Adjustments
Møller et al, 1994
(Denmark)
Cohort 2/26 Cohort Non-obese 1.0 (reference) 1.0 (reference) Age
14 531/29 434 Obese 0.5 (0.1–1.8) 1.4 (0.9–2.1)
Strom et al, 1995
(Mexico)
C–C 65 110 Men and women Age, sex
o24.0 1.0 (reference)
24.0–25.9 1.5 (0.5–4.6)
26.0–28.0 2.2 (0.7–8.4)
428.0 1.6 (0.4–6.1)
Zatonski et al, 1997
(Multicenter
b)
C–C 44/145 798/681 Quartile 1 1.0 (reference) 1.0 (reference) Age, center,
education, alcohol,
smoking, response
status
Quartile 2 1.0 (0.3–3.0) 1.7 (0.9–3.1)
Quartile 3 0.7 (0.3–2.0) 1.5 (0.8–3.0)
Quartile 4 1.0 (0.3–2.8) 2.1 (1.2–3.8)
Wolk et al, 2001
(Sweden)
Cohort 2/29 Cohort Non-obese 1.0 (reference) 1.0 (reference) Age, calendar year
8165/19 964 Obese 0.9 (0.1–3.4) 1.7 (1.1–2.5)
Serra et al, 2002
(Chile)
C–C 114 114 Men and women Age, sex
o25.0 1.0 (reference)
25.0–29.9 0.8 (0.4–1.4)
X30.0 0.9 (0.4–1.8)
Calle et al, 2003
(United States)
Cohort 180/304 Cohort 18.5–24.9 1.00 (reference) 1.00 (reference) Age, race, marital
status, education, 404 576/495 477 25.0–29.9 1.34 (0.97–1.84) 1.12 (0.86–1.47)
smoking, physical
activity, aspirin use,
estrogen-
replacement
therapy (women),
alcohol, dietary
factors
X30.0 1.76 (1.06–2.94) 2.13 (1.56–2.90)
Samanic et al, 2004
(United States)
Cohort 291 whites/ Cohort White men Black men Age, calendar year
47 blacks 366 8486 white Non-obese 1.00 (reference) 1.00 (reference)
men/832 214 black
men
Obese 1.70 (1.13–2.57) 0.93 (0.23–3.86)
Kuriyama et al,
2005 (Japan)
Cohort 9/24 Cohort 18.5–24.9 1.00 (reference) 1.00 (reference) Age, smoking, type
of health 12 485/15 054 25.0–27.4 0.46 (0.05–3.93)
c 0.83 (0.23–2.98)
insurance, intakes
of alcohol, meat,
27.5–29.9 3.43 (1.19–9.94)
fish, fruits,
vegetables, bean-
paste
X30.0 4.45 (1.39–14.2)
soup
d
Oh et al, 2005
(Korea)
Cohort 182 Cohort 18.5–22.9 1.00 (reference) Age, area of
residence, smoking, 781 283/– 23.0–24.9 1.55 (1.10–2.20)
exercise, alcohol 25.0–26.9 1.15 (0.74–1.80)
X27.0 1.25 (0.70–2.24)
Engeland et al,
2006 (Norway)
Cohort 628/1087 Cohort 18.5–24.9 1.00 (reference) 1.00 (reference) Age, birth cohort
962 901/1037 077 25.0–29.9 1.00 (0.84–1.17) 1.27 (1.10–1.47)
X30.0 1.38 (1.01–1.89) 1.88 (1.60–2.21)
Samanic et al, 2006
(Sweden)
Cohort 109 Cohort 18.5–24.9 1.00 (reference) Age, smoking
362 552/– 25.0–29.9 0.93 (0.62–1.39)
X30.0 1.40 (0.73–2.70)
BMI¼body mass index; C–C¼case–control study; CI¼confidence interval.
aRelative risks are rate ratios, odds ratios, or standardised incidence ratios.
bMulticentre case–
control study conducted in five centres located in Australia (Adelaide), Canada (Montreal and Toronto), The Netherlands (Utrecht), and Poland (Opole).
cThe highest BMI
category for men was 25.0–27.4kgm
–2; there was only one case in this category.
dOdds ratios for women were further controlled for age at menarche, age at end of first
pregnancy, and menopausal status.
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body weight is a risk factor for gallbladder cancer, suggesting that
it may in part be prevented by maintaining a healthy body
weight.
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Figure 1 Relative risks of gallbladder cancer associated with obesity. Relative risk estimates are for comparison of individuals in the ‘obese’ category
compared to those with ‘normal weight’. M¼men; W¼women.
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